VHL and renal cell carcinoma: Additionally, in VHL-deficient RCC cells, siRNA-mediated downregulation of MDM2 results in decreased protein levels of HIF-1α and HIF-2α while increasing the expression of VEGF and plasminogen activator inhibitor-1 proteins (Carroll and Ashcroft, 2008).